Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis. / Mezza, Teresa; Moffa, Simona; Ferraro, Pietro Manuel; Quero, Giuseppe; Capece, Umberto; Carfi, Andrea; Cefalo, Chiara M. A.; Cinti, Francesca; Sorice, Gian Pio; Impronta, Flavia; Mari, Andrea; Pontecorvi, Alfredo; Alfieri, Sergio; Holst, Jens J.; Giaccari, Andrea.

In: Journal of Clinical Endocrinology & Metabolism, Vol. 104, No. 7, 2019, p. 2685-2694.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Mezza, T, Moffa, S, Ferraro, PM, Quero, G, Capece, U, Carfi, A, Cefalo, CMA, Cinti, F, Sorice, GP, Impronta, F, Mari, A, Pontecorvi, A, Alfieri, S, Holst, JJ & Giaccari, A 2019, 'Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis', Journal of Clinical Endocrinology & Metabolism, vol. 104, no. 7, pp. 2685-2694. https://doi.org/10.1210/jc.2018-02804

APA

Mezza, T., Moffa, S., Ferraro, P. M., Quero, G., Capece, U., Carfi, A., Cefalo, C. M. A., Cinti, F., Sorice, G. P., Impronta, F., Mari, A., Pontecorvi, A., Alfieri, S., Holst, J. J., & Giaccari, A. (2019). Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis. Journal of Clinical Endocrinology & Metabolism, 104(7), 2685-2694. https://doi.org/10.1210/jc.2018-02804

Vancouver

Mezza T, Moffa S, Ferraro PM, Quero G, Capece U, Carfi A et al. Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis. Journal of Clinical Endocrinology & Metabolism. 2019;104(7):2685-2694. https://doi.org/10.1210/jc.2018-02804

Author

Mezza, Teresa ; Moffa, Simona ; Ferraro, Pietro Manuel ; Quero, Giuseppe ; Capece, Umberto ; Carfi, Andrea ; Cefalo, Chiara M. A. ; Cinti, Francesca ; Sorice, Gian Pio ; Impronta, Flavia ; Mari, Andrea ; Pontecorvi, Alfredo ; Alfieri, Sergio ; Holst, Jens J. ; Giaccari, Andrea. / Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis. In: Journal of Clinical Endocrinology & Metabolism. 2019 ; Vol. 104, No. 7. pp. 2685-2694.

Bibtex

@article{bf6c3c4d54244638a64578a3a1b1cbeb,
title = "Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis",
abstract = "Objective: Changes in bile flow after bariatric surgery may beneficially modulate secretion of insulin and incretins, leading to diabetes remission. However, the exact mechanism(s) involved is still unclear. Here, we propose an alternative method to investigate the relationship between alterations in physiological bile flow and insulin and incretin secretion by studying changes in gutpancreatic function in extrahepatic cholestasis in nondiabetic humans. Methods: To pursue this aim, 58 nondiabetic patients with recent diagnosis of periampullary tumors underwent an oral glucose tolerance test (OGTT), and a subgroup of 16 patients also underwent 4-hour mixed meal tests and hyperinsulinemic-euglycemic clamps. Results: The analysis of the entire cohort revealed a strong inverse correlation between total bilirubin levels and insulinogenic index. When subjects were divided on the basis of bilirubin levels, used as a marker of altered bile flow, subjects with high bilirubin levels displayed inferior glucose control and decreased insulin secretion during the OGTT. Altered bile flow elicited a markedly greater increase in glucagon and glucagon-like peptide 1 (GLP-1) secretion at fasting state, and following the meal, both glucagon and GLP-1 levels remained increased over time. Conversely, Glucose-dependent insulinotropic polypeptide (GIP) levels were comparable at the fasting state, whereas the increase following meal ingestion was significantly blunted with high bilirubin levels. We reveal strong correlations between total bilirubin and glucagon and GLP-1 levels. Conclusions: Our findings suggest that acute extrahepatic cholestasis determines major impairment in enteroendocrine gut-pancreatic secretory function. The altered bile flow may determine a direct deleterious effect on beta-cell function, perhaps mediated by the impairment of incretin hormone function.",
author = "Teresa Mezza and Simona Moffa and Ferraro, {Pietro Manuel} and Giuseppe Quero and Umberto Capece and Andrea Carfi and Cefalo, {Chiara M. A.} and Francesca Cinti and Sorice, {Gian Pio} and Flavia Impronta and Andrea Mari and Alfredo Pontecorvi and Sergio Alfieri and Holst, {Jens J.} and Andrea Giaccari",
year = "2019",
doi = "10.1210/jc.2018-02804",
language = "English",
volume = "104",
pages = "2685--2694",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "Oxford University Press",
number = "7",

}

RIS

TY - JOUR

T1 - Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis

AU - Mezza, Teresa

AU - Moffa, Simona

AU - Ferraro, Pietro Manuel

AU - Quero, Giuseppe

AU - Capece, Umberto

AU - Carfi, Andrea

AU - Cefalo, Chiara M. A.

AU - Cinti, Francesca

AU - Sorice, Gian Pio

AU - Impronta, Flavia

AU - Mari, Andrea

AU - Pontecorvi, Alfredo

AU - Alfieri, Sergio

AU - Holst, Jens J.

AU - Giaccari, Andrea

PY - 2019

Y1 - 2019

N2 - Objective: Changes in bile flow after bariatric surgery may beneficially modulate secretion of insulin and incretins, leading to diabetes remission. However, the exact mechanism(s) involved is still unclear. Here, we propose an alternative method to investigate the relationship between alterations in physiological bile flow and insulin and incretin secretion by studying changes in gutpancreatic function in extrahepatic cholestasis in nondiabetic humans. Methods: To pursue this aim, 58 nondiabetic patients with recent diagnosis of periampullary tumors underwent an oral glucose tolerance test (OGTT), and a subgroup of 16 patients also underwent 4-hour mixed meal tests and hyperinsulinemic-euglycemic clamps. Results: The analysis of the entire cohort revealed a strong inverse correlation between total bilirubin levels and insulinogenic index. When subjects were divided on the basis of bilirubin levels, used as a marker of altered bile flow, subjects with high bilirubin levels displayed inferior glucose control and decreased insulin secretion during the OGTT. Altered bile flow elicited a markedly greater increase in glucagon and glucagon-like peptide 1 (GLP-1) secretion at fasting state, and following the meal, both glucagon and GLP-1 levels remained increased over time. Conversely, Glucose-dependent insulinotropic polypeptide (GIP) levels were comparable at the fasting state, whereas the increase following meal ingestion was significantly blunted with high bilirubin levels. We reveal strong correlations between total bilirubin and glucagon and GLP-1 levels. Conclusions: Our findings suggest that acute extrahepatic cholestasis determines major impairment in enteroendocrine gut-pancreatic secretory function. The altered bile flow may determine a direct deleterious effect on beta-cell function, perhaps mediated by the impairment of incretin hormone function.

AB - Objective: Changes in bile flow after bariatric surgery may beneficially modulate secretion of insulin and incretins, leading to diabetes remission. However, the exact mechanism(s) involved is still unclear. Here, we propose an alternative method to investigate the relationship between alterations in physiological bile flow and insulin and incretin secretion by studying changes in gutpancreatic function in extrahepatic cholestasis in nondiabetic humans. Methods: To pursue this aim, 58 nondiabetic patients with recent diagnosis of periampullary tumors underwent an oral glucose tolerance test (OGTT), and a subgroup of 16 patients also underwent 4-hour mixed meal tests and hyperinsulinemic-euglycemic clamps. Results: The analysis of the entire cohort revealed a strong inverse correlation between total bilirubin levels and insulinogenic index. When subjects were divided on the basis of bilirubin levels, used as a marker of altered bile flow, subjects with high bilirubin levels displayed inferior glucose control and decreased insulin secretion during the OGTT. Altered bile flow elicited a markedly greater increase in glucagon and glucagon-like peptide 1 (GLP-1) secretion at fasting state, and following the meal, both glucagon and GLP-1 levels remained increased over time. Conversely, Glucose-dependent insulinotropic polypeptide (GIP) levels were comparable at the fasting state, whereas the increase following meal ingestion was significantly blunted with high bilirubin levels. We reveal strong correlations between total bilirubin and glucagon and GLP-1 levels. Conclusions: Our findings suggest that acute extrahepatic cholestasis determines major impairment in enteroendocrine gut-pancreatic secretory function. The altered bile flow may determine a direct deleterious effect on beta-cell function, perhaps mediated by the impairment of incretin hormone function.

U2 - 10.1210/jc.2018-02804

DO - 10.1210/jc.2018-02804

M3 - Journal article

C2 - 30874733

VL - 104

SP - 2685

EP - 2694

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 7

ER -

ID: 225670557